Therefore, the osteolytic MRMT-1 breast-derived bone metastasis consists of ERα (+), HER2 (−), Ki-67 (+) tumor cells, which can be classified as a luminal B invasive adenocarcinoma40,41. The gene discussed is ESR1; the disease is neoplasm.